Source: Virtual Congress 2021 – New insights into the pathophysiology and prognosis of COPD



Rating:

Share or cite this content

Citations should be made in the following way:
A. Kharat (Montréal (QC), Canada), M. Girard (Montréal (QC), Canada), B. Dube (Montréal (QC), Canada). Ultrasound diaphragm activity as a marker of clinical status and prognosis in acute exacerbations of COPD. 2559

Member's Comments

No comment yet.

Related content which might interest you: Ultrasonographic assessment of diaphragm dysfunction in acute exacerbations of COPD Source: International Congress 2017 – Imaging markers for COPD and asthma Year: 2017 The prognostic value of cardiac and inflammatory biomarkers in acute exacerbations of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Clinical and exacerbation characteristics may predict treatment response in acute exacerbations of COPD Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Clinical value of C-reactive protein in severe acute exacerbations of COPD Source: Annual Congress 2005 - COPD - acute exacerbations Year: 2005 Temporal profile and clinical utility of inflammatory markers in patients with acute exacerbation of COPD Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008 Factors associated with poor prognostic outcome in acute exacerbation of COPD Source: Annual Congress 2009 - Treatment of airways disease Year: 2009 The role of biomarkers in predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013 Impact of patient nutritional status on acute exacerbation of COPD Source: Annual Congress 2012 - COPD exacerbation Year: 2012 Acute exacerbation phenotypes of asthma and COPD: impact on clinical outcomes Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Time to move from prognostication to diagnosis and treatment of heart disease in acute exacerbation of COPD Source: Eur Respir J, 49 (6) 1700912; 10.1183/13993003.00912-2017 Year: 2017 The effectiveness of early pulmonary rehabilitation in acute exacerbation of COPD in the terms of functional and systemic markers. Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation Year: 2020 Usefulness of admission red cell distribution Width as a predictor of early mortality in patients with severe exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD exacerbation Year: 2012 The relationship of exacerbations and lung function decline to radiologic characteristics in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 512s Year: 2005 Sit-to-stand ability in patients hospitalised for acute exacerbation of COPD: Clinical characteristics and short-term outcomes Source: International Congress 2015 – New insights into exercise and muscle performance Year: 2015 Acute exacerbations of chronic obstructive pulmonary disease, clinical characteristics and predictors of exacerbations rate Source: Eur Respir J 2006; 28: Suppl. 50, 625s Year: 2006 Copeptin – a marker for differential diagnosis between acute exacerbation of COPD and heart failure in patients with acute dyspnea Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021 Cardiac biomarkers and outcomes of COPD exacerbations Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Quantitative CT characterisation of stable COPD patients relates to COPD severity and exacerbation frequency Source: Annual Congress 2006 - COPD: imaging and computer applications Year: 2006 Clinical parameters predict the risk of acute exacerbation of COPD better than bronchial obstruction degree Source: Eur Respir J 2001; 18: Suppl. 33, 210s Year: 2001